Form 4 for AVTR Avantor, Inc.
Accepted 2026-02-25 00:00:00 ET · period of report 2026-02-23 · accession 0001628280-26-011809 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-02-25 | 2026-02-23 | AVTR | Gourdier Benoit | EVP, Bioscience, Medtech | F - Tax | $8.89 | -3,029 | 362.9K | -0.8% | -$26.9K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-02-23 | F | D | 3,029 | $8.89 | 362,859 | D | — | — |